- Home
- CUE vs MOBX Comparison
CUE vs MOBX Comparison
Compare CUE & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- MOBX
- Stock Information
- Founded
- CUE 2014
- MOBX 2020
- Country
- CUE United States
- MOBX United States
- Employees
- CUE N/A
- MOBX N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- MOBX
- Sector
- CUE Health Care
- MOBX
- Exchange
- CUE Nasdaq
- MOBX Nasdaq
- Market Cap
- CUE 59.5M
- MOBX 57.1M
- IPO Year
- CUE 2018
- MOBX N/A
- Fundamental
- Price
- CUE $0.74
- MOBX $0.93
- Analyst Decision
- CUE Strong Buy
- MOBX
- Analyst Count
- CUE 2
- MOBX 0
- Target Price
- CUE $3.00
- MOBX N/A
- AVG Volume (30 Days)
- CUE 116.9K
- MOBX 1.7M
- Earning Date
- CUE 08-12-2025
- MOBX 08-13-2025
- Dividend Yield
- CUE N/A
- MOBX N/A
- EPS Growth
- CUE N/A
- MOBX N/A
- EPS
- CUE N/A
- MOBX N/A
- Revenue
- CUE $8,286,000.00
- MOBX $10,984,000.00
- Revenue This Year
- CUE N/A
- MOBX N/A
- Revenue Next Year
- CUE $10.19
- MOBX N/A
- P/E Ratio
- CUE N/A
- MOBX N/A
- Revenue Growth
- CUE N/A
- MOBX 180.13
- 52 Week Low
- CUE $0.45
- MOBX $0.55
- 52 Week High
- CUE $1.99
- MOBX $2.47
- Technical
- Relative Strength Index (RSI)
- CUE 38.09
- MOBX 45.49
- Support Level
- CUE $0.77
- MOBX $1.00
- Resistance Level
- CUE $0.79
- MOBX $1.19
- Average True Range (ATR)
- CUE 0.04
- MOBX 0.16
- MACD
- CUE -0.01
- MOBX -0.01
- Stochastic Oscillator
- CUE 12.87
- MOBX 14.17
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About MOBX Mobix Labs Inc.
Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.